-
1 Comment
SonoScape Medical Corp is currently in a long term uptrend where the price is trading 21.1% above its 200 day moving average.
From a valuation standpoint, the stock is 10.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.6.
SonoScape Medical Corp's total revenue sank by 7.8% to $226M since the same quarter in the previous year.
Its net income has increased by 118.6% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 185.1% to $35M since the same quarter in the previous year.
Based on the above factors, SonoScape Medical Corp gets an overall score of 4/5.
| ISIN | CNE100002P91 |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Medical Devices |
| Dividend Yield | 0.4% |
|---|---|
| Market Cap | 12B |
| PE Ratio | 177.33 |
| Target Price | 36.1133 |
| Beta | -0.39 |
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery solutions, such as camera systems and flexible endoscopes; veterinary ultrasound and endoscopy solutions; and intravascular intervention products. It also provides face-to-face and online training for ultrasound and endoscopy systems; technical and spare parts support; preventive maintenance, calibration, breakdown repair, and other field services; and upgrade services. In addition, the company is involved in the software industry. SonoScape Medical Corp. was incorporated in 2002 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300633.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
